1 April 2023 false Taxfiler 2024.6 05840919business:PrivateLimitedCompanyLtd2023-04-012024-03-31 058409192023-03-31 058409192023-04-012024-03-31 05840919business:AuditExemptWithAccountantsReport2023-04-012024-03-31 05840919business:FilletedAccounts2023-04-012024-03-31 058409192024-03-31 05840919business:Director12023-04-012024-03-31 05840919business:RegisteredOffice2023-04-012024-03-31 058409192023-03-31 05840919core:WithinOneYear2024-03-31 05840919core:WithinOneYear2023-03-31 05840919core:AfterOneYear2024-03-31 05840919core:AfterOneYear2023-03-31 05840919core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 05840919core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 05840919core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 05840919core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 05840919core:PreviouslyStatedAmount2024-03-31 05840919core:PreviouslyStatedAmount2023-03-31 05840919business:SmallEntities2023-04-012024-03-31 05840919countries:EnglandWales2023-04-012024-03-31 05840919core:FurnitureFittings2023-04-012024-03-31 05840919core:PlantMachinery2023-03-31 05840919core:PlantMachinery2024-03-31 05840919business:OrdinaryShareClass12023-04-012024-03-31 05840919business:OrdinaryShareClass12022-04-012023-03-31 058409192022-04-012023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 05840919 (England and Wales)
Z Pharm Limited Filleted accounts for the year ended 31 March 2024
Z Pharm Limited Filleted accounts Contents
Page
- 2 -
Z Pharm Limited Company Information for the year ended 31 March 2024
Director
Hamida Mohamed Faruq
Company Number
05840919 (England and Wales)
Registered Office
107 Turnbull Drive Leicester LE3 2JW
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Z Pharm Limited Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Investments
436,047 
436,047 
Current assets
Cash at bank and in hand
- 
20,519 
Creditors: amounts falling due within one year
(1,333)
(872)
Net current (liabilities)/assets
(1,333)
19,647 
Total assets less current liabilities
434,714 
455,694 
Creditors: amounts falling due after more than one year
(311,260)
(342,362)
Net assets
123,454 
113,332 
Capital and reserves
Called up share capital
2 
2 
Profit and loss account
123,452 
113,330 
Shareholders' funds
123,454 
113,332 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 October 2024 and were signed on its behalf by
Hamida Mohamed Faruq Director Company Registration No. 05840919
- 4 -
Z Pharm Limited Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
Z Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 05840919. The registered office is 107 Turnbull Drive, Leicester, LE3 2JW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% straight line
Investment property
Investment property is included at market fair value. Gains are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Investments
Investments in shares are included at fair value.
- 5 -
Z Pharm Limited Notes to the Accounts for the year ended 31 March 2024
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 April 2023
476 
At 31 March 2024
476 
Depreciation
At 1 April 2023
476 
At 31 March 2024
476 
Net book value
At 31 March 2024
- 
5
Investments
Other investments 
£ 
Valuation at 1 April 2023
436,047 
Valuation at 31 March 2024
436,047 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Trade creditors
872 
436 
Accruals
461 
436 
1,333 
872 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
- 
30,162 
Amounts owed to group undertakings and other participating interests
311,260 
312,200 
311,260 
342,362 
8
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2 
2 
9
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -